Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Total Current Liabilities: 2017-2019

Historic Total Current Liabilities for Astria Therapeutics (ATXS) over the last 3 years, with Sep 2019 value amounting to $5.6 million.

  • Astria Therapeutics' Total Current Liabilities rose 34.81% to $5.6 million in Q3 2019 from the same period last year, while for Sep 2019 it was $5.6 million, marking a year-over-year increase of 34.81%. This contributed to the annual value of $4.2 million for FY2018, which is 30.67% down from last year.
  • Per Astria Therapeutics' latest filing, its Total Current Liabilities stood at $5.6 million for Q3 2019, which was up 7.60% from $5.2 million recorded in Q2 2019.
  • In the past 5 years, Astria Therapeutics' Total Current Liabilities registered a high of $8.1 million during Q2 2017, and its lowest value of $4.1 million during Q3 2018.
  • For the 3-year period, Astria Therapeutics' Total Current Liabilities averaged around $5.7 million, with its median value being $5.3 million (2018).
  • Per our database at Business Quant, Astria Therapeutics' Total Current Liabilities crashed by 45.43% in 2018 and then skyrocketed by 34.81% in 2019.
  • Over the past 3 years, Astria Therapeutics' Total Current Liabilities (Quarterly) stood at $6.0 million in 2017, then plummeted by 30.67% to $4.2 million in 2018, then skyrocketed by 34.81% to $5.6 million in 2019.
  • Its Total Current Liabilities was $5.6 million in Q3 2019, compared to $5.2 million in Q2 2019 and $4.3 million in Q1 2019.